Skip to main content

Table 2 Comparison of main signs and symptoms between survivors and non-survivors patients with visceral leishmaniasis

From: Hyponatremia and risk factors for death in human visceral leishmaniasis: new insights from a cross-sectional study in Brazil

  Non-survivors (N = 34) Survivors (N = 251) p
Fever 30 (88.2%) 229 (91.2%) 0.569
Hepato-splenomegaly 22 (64.7%) 199 (79.3%) 0.056
Weight loss 22 (64.7%) 185 (74%) 0.253
Asthenia 16 (47.1%) 156 (62.2%) 0.091
Cough 13 (38.2%) 95 (37.8%) 0.965
Abdominal pain 15 (44.1%) 84 (33.5%) 0.221
Diarrhea 12(35.3%) 57 (22.7%) 0.108
Vomiting 13 (38.2%) 54 (21.5%) 0.031
Dyspnea 13 (38.2%) 42 (16.7%) 0.003
Edema 11 (32.4%) 42 (16.7%) 0.028
Jaundice 16 (47.1%) 36 (14.3%) <0.001
Dehydration 8 (23.5%) 27 (10.8%) 0.033
Nose bleeding 11 (4.8%) 13 (5.2%) 0.128
Pulmonary crackles 4 (11.8%) 10 (4.0%) 0.049
Oliguria 3 (8.8%) 2 (0.8%) 0.001
Hypotension 0 (0%) 2 (0.8%) 0.602
  1. Chi-squared test was used. P ≤ 0.05 was considered statistically significant